The U.S. patent application concerning histamine biosynthesis production claims delves into methods for producing histamine, a biogenic amine with various physiological roles. These applications often focus on optimizing production processes, potentially for pharmaceutical or industrial use.
What methods are claimed for histamine production?
Patent applications in this area typically describe methods involving microbial fermentation or enzymatic synthesis. For instance, claims might detail specific strains of bacteria or yeast genetically engineered to enhance histamine yield, or novel enzyme systems capable of catalyzing the conversion of histidine to histamine with high efficiency. The processes often specify parameters such as temperature, pH, substrate concentration, and fermentation time to maximize production [1].
How do these patents protect histamine production technology?
Protection is sought for the novel aspects of the claimed production methods. This can include the specific microorganisms used, the genetic modifications introduced, the composition of culture media, the purification techniques for the produced histamine, and the overall process design. By obtaining patent rights, companies can prevent others from practicing these specific patented methods for a set period [2].
What are the potential applications of patented histamine production methods?
The histamine produced through these methods could have various applications. In the pharmaceutical industry, histamine itself or its derivatives are used in diagnostic tests and in the treatment of certain conditions. Beyond medicine, histamine can be used in research settings to study its biological functions and its role in allergic reactions and other physiological processes [3].
When do these patent applications typically expire?
Patent applications, once granted as patents, generally have a term of 20 years from the date of filing. However, this term can be affected by factors such as patent term extensions for pharmaceutical products or other regulatory delays. Information on specific patent expiry dates can be found through patent databases, such as those provided by DrugPatentWatch.com [2].
What are the key challenges in histamine biosynthesis production?
Challenges in histamine biosynthesis production can include achieving high purity levels, controlling side-product formation, scaling up the process for commercial viability, and managing the potential toxicity or allergenicity of histamine itself. Patent claims often aim to address these challenges by introducing innovative solutions [1, 3].
Who are the main players developing histamine production patents?
Companies and research institutions involved in biotechnology, pharmaceuticals, and industrial enzyme production are typically the entities filing patents related to histamine biosynthesis. These can range from large pharmaceutical corporations to specialized biotech startups and academic research groups [2].
How does histamine production relate to drug development?
While histamine itself is a direct therapeutic agent or diagnostic tool in some cases, its biosynthesis is also relevant to understanding and developing drugs that modulate histamine receptors or histamine metabolism. Patents in this area could indirectly support the development of new antihistamines or drugs that target histamine-related pathways [3].
Sources:
[1] https://patents.google.com/
[2] https://www.drugpatentwatch.com/
[3] https://pubmed.ncbi.nlm.nih.gov/